Download PDF
Thromb Haemost 1985; 54(02): 498-502
DOI: 10.1055/s-0038-1657882
Original Article
Schattauer GmbH Stuttgart

Endothelial Cells Degrade Extracellular Matrix Proteins Produced In Vitro

Walter E Laug
The Division of Hematology-Oncology, Childrens Hospital of Los Angeles and University of Southern California, School of Medicine, Los Angeles, California, USA
,
Mark E Weinblatt
The Division of Hematology-Oncology, Childrens Hospital of Los Angeles and University of Southern California, School of Medicine, Los Angeles, California, USA
,
Peter A Jones
The Division of Hematology-Oncology, Childrens Hospital of Los Angeles and University of Southern California, School of Medicine, Los Angeles, California, USA
› Author Affiliations
Further Information

Publication History

Received 05 May 1985

Accepted 06 June 1985

Publication Date:
18 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Bovine aortic endothelial cells (BAEC) were grown on extracellular matrices produced by vascular smooth muscle cells or fetal bovine endothelial cells. The glycoprotein components of these complex substrates were degraded through activation of the serum zymogen plasminogen to plasmin, as well as by a plasmino- gen independent protease(s). The plasminogen independent enzyme might be a protease with elastolytic activity since the BAEC digested elastin present in smooth muscle cell derived matrices. The cells also displayed collagenolytic activity on both types of matrices.

The addition of the tumor promoter 12-0-tetradecanoyl-phorbol-13-acetate (TPA) (10−7 M) to the culture medium enhanced considerably the plasminogen activator and collagenolytic activities elaborated by BAEC resulting in an increased degradation rate of matrix glycoprotein and collagen components, whereas the elastolytic activity remained unaffected. Dex- amethasone (10−7 M), although suppressing plasminogen activator (PA) production by BAEC, did not alter their elastolytic activity allowing the cells to degrade the glycoprotein components of the matrices at an unchanged rate. The collagenolytic activity of the BAEC remained unaffected by dexamethasone.

These studies demonstrate that BAEC elaborate different proteolytic enzyme activities allowing them to degrade various components of extracellular matrices. These enzymatic activities may be modulated by certain agents thus changing the degradative capabilities of the BAEC.

Keywords

Endothelial Cells - Extracellular Matrix - Proteases - Matrix degradation -
 

  • References

  • 1 Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977; 14: 53-56
    CrossrefPubMedGoogle Scholar
  • 2 Hay ED. Extracellular matrix. J Cell Biol 1981; 91: 205-223
    CrossrefPubMedGoogle Scholar
  • 3 Jones PA, Scott-Burden T, Gevers W. Glycoprotein, elastin and collagen secretion by rat smooth muscle cells. Proc Natl Acad Sci USA 1979; 76: 353-357
    CrossrefPubMedGoogle Scholar
  • 4 Laug WE, DeClerck YA, Jones PA. Degradation of the subendothelial matrix by tumor cells. Cancer Res 1983; 43: 1827-1834
    PubMedGoogle Scholar
  • 5 Jones PA, DeClerck YA. Destruction of extracellular matrices containing glycoproteins, elastin and collagen by metastatic human tumor cells. Cancer Res 1980; 40: 3222-3227
    PubMedGoogle Scholar
  • 6 Levin EG, Loskutoff DJ. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol 1982; 94: 631-636
    CrossrefPubMedGoogle Scholar
  • 7 Laug WE. Glucocorticoids inhibit plasminogen activator production by endothelial cells. Thromb Haemostas 1983; 50: 888-892
    PubMedGoogle Scholar
  • 8 Moscatelli D, Jaffe D, Rifkin DB. Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured human endothelial cells. Cell 1980; 20: 343-351
    CrossrefPubMedGoogle Scholar
  • 9 Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz M, Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (London) 1980; 284: 67-68
    CrossrefPubMedGoogle Scholar
  • 10 Gross JL, Moscatelli EA, Jaffe EA, Rifkin DB. Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biology 1982; 85: 974-981
    PubMedGoogle Scholar
  • 11 Kalebic T, Garbisa S, Glaser B, Liotta LA. Basement membrane collagen: Degradation by migrating endothelial cells. Science 1983; 221: 281-283
    CrossrefPubMedGoogle Scholar
  • 12 Laug WE, Tokes ZA, Benedict WF, Sorgente N. Anchorage independent growth and plasminogen activator production by bovine endothelial cells. J Cell Biol 1980; 84: 281-293
    CrossrefPubMedGoogle Scholar
  • 13 Laug WE. Secretion of plasminogen activators by cultured bovine endothelial cells: Partial purification, characterization and evidence for multiple forms. Thromb Haemostas 1981; 45: 219-224
    PubMedGoogle Scholar
  • 14 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
    CrossrefPubMedGoogle Scholar
  • 15 Laug WE, Jones PA, Benedict WF. Studies on the relationship between fibrinolysis of cultured cells and malignancy. J Natl Cancer Inst 1975; 54: 173-179
    CrossrefPubMedGoogle Scholar
  • 16 Loskutoff DJ, Edgington TS. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA 1977; 74: 3903-3907
    CrossrefPubMedGoogle Scholar
  • 17 Keksi-Oja J, Vaheri A. The cellular target for the plasminogen activator, urokinase, in human fibroblasts-66000 Dalton protein. Biochim Biophys Acta 1982; 720: 141-146
    CrossrefPubMedGoogle Scholar
  • 18 Quigley JP. Morphological alterations and degradative ability of RSV-transformed chick fibroblasts when cultured on the extracellular matrix produced by normal chick fibroblasts. Proc Am Assoc Cancer Res 1983; 24: 29
    PubMedGoogle Scholar